The global push for 'brain health'—spearheaded by governments, industry, and philanthropies—aims to mirror successful public health frameworks for cancer and heart disease, focusing on early screening and prevention to combat neurodegenerative disorders like Alzheimer’s. As highlighted in a recent STAT News opinion piece, this noble ambition harbors a critical oversight: the systematic exclusion of mental illness from brain health discussions. This is not merely a semantic gap but a scientific and strategic misstep with profound implications. Mental illnesses such as depression and substance use disorders are not peripheral issues but key drivers of cognitive decline and late-life neurodegeneration. The Lancet Commission identifies depression as a leading modifiable risk factor for dementia, rivaling cardiovascular health in impact. Yet, mainstream narratives often prioritize physical health trends over psychiatric conditions, perpetuating a stigma that undermines holistic wellness.

Digging deeper, the STAT piece misses a crucial historical context: mental health has long been siloed from physical health in medical research and policy, a divide rooted in outdated Cartesian dualism that separates mind and body. This isn’t new—decades of underfunding for psychiatric research compared to neurological disorders reflect entrenched biases. For instance, the National Institutes of Health (NIH) allocated only 6% of its 2022 budget to mental health research, despite mental disorders contributing to 13% of the global disease burden (WHO, 2020). This disparity shapes public perception and policy, sidelining mental illness even when evidence, like the 2020 Lancet Psychiatry study (n=1.2 million, observational), shows midlife depression doubles dementia risk. While the STAT article notes biological mechanisms—such as brain atrophy and reduced transcription factors—it underplays how socioeconomic factors amplify this. Poverty, stigma, and lack of access to mental health care exacerbate untreated psychiatric conditions, creating a vicious cycle of vulnerability to neurodegeneration, particularly in low-income populations.

Mainstream coverage often glosses over these systemic issues, focusing instead on high-profile neurodegenerative diseases. What’s missing is the intersectionality of mental health stigma with race, gender, and class—groups disproportionately affected by both psychiatric illness and dementia risk factors are rarely centered in brain health campaigns. A 2021 meta-analysis in JAMA Psychiatry (n=50 studies, observational) found that Black and Hispanic populations face higher rates of untreated depression and subsequent cognitive decline, yet policy frameworks rarely address these disparities. Additionally, the STAT piece overlooks the potential of integrated care models. Programs like the Collaborative Care Model, backed by RCTs (n=1,800, high quality), show that embedding mental health treatment in primary care settings improves outcomes for depression and reduces later-life cognitive impairment by 20%. Scaling such interventions could reshape brain health strategies, but they remain under-discussed.

The broader pattern is clear: mental health stigma continues to distort scientific priorities and public health agendas. Ignoring psychiatric conditions in brain health discussions isn’t just a missed opportunity—it’s a perpetuation of harm. If we’re serious about extending cognitive lifespans, mental illness must be treated as a core pillar of neuroscience, not an afterthought. This requires not only research investment but also cultural shifts to dismantle the stigma that keeps mental health on the margins.